Cardiovascular Disease Early Detection and Prevention Act of 2026

This bill requires group health plans, individual and group health insurance, Medicare, and Medicaid to cover certain cardiovascular tests, specifically for lipoprotein(a) and apolipoprotein B levels, without cost sharing for individuals with specified risk factors.

Sec. 3, Coverage requirements: The bill amends the Public Health Service Act to add testing for lipoprotein(a) and apolipoprotein B as a required preventive service under group health plans and insurance, for individuals with a family history of premature cardiovascular disease, personal history of heart attack, stroke, or high LDL cholesterol, diabetes, obesity, or other recognized risk factors.

Sec. 3, Medicare: The bill adds these tests to Medicare's covered preventive services and prohibits cost sharing for them when furnished to eligible individuals.

Sec. 3, Medicaid: The bill adds these tests as a mandatory Medicaid service for eligible individuals, prohibits cost sharing, and requires benchmark and benchmark-equivalent plans to cover them.

Sec. 3, Effective date: The changes for group health plans and insurance apply to plan years starting 180 days after enactment; Medicare and Medicaid changes apply to services furnished on or after that date.